ceragenix pharmaceuticals in
(CGXP:OTC US)

Executive Profile*

Background*

Dr. Richard L. Gallo MD, PhD serves as Chief of Division for Dermatology at University of California, San Diego School of Medicine. Dr. Gallo serves as Chairman of Scientific Advisory Board at N8 Medical, LLC. Dr. Gallo serves as a Member of Scientific Advisory Board of Ceragenix Pharmaceuticals Inc. Dr. Gallo has been a Member of Scientific Advisory Board of Altea Therapeutics Corporation since August 2008. He is Associate Editor of the Journal of Dermatologic Science ... and the European Journal of Dermatology as well as Editor of the textbook, Antimicrobial Peptides in Health and Human Disease. He is a Professor of Medicine and Pediatrics at University of California. Dr. Gallo is a leading investigator in the field of skin research with a focus on the role of the innate immune system in skin health and disease, the role of antimicrobial peptides and aspects of the interaction of the skin with the immune system. He has contributed several landmark observations in the field of Dermatology, including the first description of an antimicrobial peptide in mammalian skin. Following an internship in Pediatrics at Johns Hopkins, Dr. Gallo trained at Harvard for clinical Dermatology and completed a post-doctoral fellowship there in Developmental Biology. He received his medical training at the University of Rochester, where he also received his PhD in Radiation Biology and Biophysics.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
CGXP:US	$0.00 USD	0.00

COMPETITOR COMPENSATION